Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.210
-0.100 (-7.63%)
At close: Dec 5, 2025, 4:00 PM EST
1.240
+0.030 (2.47%)
After-hours: Dec 5, 2025, 7:49 PM EST

Pliant Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Pliant Therapeutics stock have a consensus rating of "Hold" and an average price target of $3.79, which forecasts a 213.22% increase in the stock price over the next year. The lowest target is $1.50 and the highest is $10.

Price Target: $3.79 (+213.22%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$1.50$3.79$3.00$10
Change+23.97%+213.22%+147.93%+726.45%
* Price targets were last updated on Nov 7, 2025.

Analyst Ratings

The average analyst rating for Pliant Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy000000
Buy122111
Hold999999
Sell000111
Strong Sell000000
Total101111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Hold
Maintains
$3$2
HoldMaintains$3$2+65.29%Nov 7, 2025
JP Morgan
JP Morgan
Sell
Downgrades
n/a
SellDowngradesn/an/aOct 10, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$17$4
BuyMaintains$17$4+230.58%Aug 8, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
HoldReiteratesn/an/aMar 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
HoldReiteratesn/an/aMar 4, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
3.83M
EPS This Year
-2.48
from -3.47
EPS Next Year
-1.94
from -2.48
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
41.82M7.57M9.69M1.58M--3.83M
Revenue Growth
-26.70%-81.89%27.91%-83.69%---
EPS
-1.95-2.71-2.94-2.75-3.47-2.48-1.94
EPS Growth
-------
Forward PE
-------
No. Analysts
-----99
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
Highn/a15.8M
Avgn/a3.8M
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-2.50-1.60
Avg-2.48-1.94
Low-2.43-2.50

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.